Resistance to Integrase Inhibitors

被引：83
|
作者：
Metifiot, Mathieu [1 ]
Marchand, Christophe [1 ]
Maddali, Kasthuraiah [1 ]
Pommier, Yves [1 ]
机构：
[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
VIRUSES-BASEL | 2010年 / 2卷 / 07期
关键词：
AIDS; HIV-1; integrase; Raltegravir; Elvitegravir; GSK-1349572; GSK-1265744; interfacial inhibitors; resistance; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; LONG TERMINAL REPEAT; HIV-1; INTEGRASE; STRAND TRANSFER; ACTIVE-SITE; DIKETO ACID; RALTEGRAVIR RESISTANCE; CONCERTED INTEGRATION; RETROVIRAL INTEGRASE;
D O I：
10.3390/v2071347
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Integrase (IN) is a clinically validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clinical activity. The next most advanced IN inhibitor is elvitegravir. However, mutant viruses lead to treatment failure and mutations within the IN coding sequence appear to confer cross-resistance. The characterization of those mutations is critical for the development of second generation IN inhibitors to overcome resistance. This review focuses on IN resistance based on structural and biochemical data, and on the role of the IN flexible loop i.e., between residues G140-G149 in drug action and resistance.
引用
收藏
页码：1347 / 1366
页数：20
相关论文
共 50 条
  • [21] HIV-1 Group O Resistance Against Integrase Inhibitors
    Depatureaux, Agnes
    Mesplede, Thibault
    Quashie, Peter
    Oliveira, Maureen
    Moisi, Daniela
    Plantier, Jean-Christophe
    Brenner, Bluma
    Wainberg, Mark A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (01) : 9 - 15
  • [22] Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
    Chang, Sui-Yuan
    Lin, Pi-Han
    Cheng, Chien-Lin
    Chen, Mao-Yuan
    Sun, Hsin-Yun
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Su, Yi-Ching
    Su, Li-Hsin
    Chang, Shu-Fang
    Liu, Wen-Chun
    Hung, Chien-Ching
    Chang, Shan-Chwen
    SCIENTIFIC REPORTS, 2016, 6
  • [23] HIV-1 Integrase Inhibitors Resistance: Update of the Current Literature
    Alberto Enrico Maraolo
    Current Treatment Options in Infectious Diseases, 2017, 9 (1) : 44 - 51
  • [24] Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
    Malet, Isabelle
    Subra, Frederic
    Charpentier, Charlotte
    Collin, Gilles
    Descamps, Diane
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Delelis, Olivier
    MBIO, 2017, 8 (05):
  • [25] Transmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule
    Hurt, Christopher B.
    ANTIVIRAL THERAPY, 2011, 16 (02) : 137 - 140
  • [26] Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
    Alvarez, Marta
    Casas, Paz
    de Salazar, Adolfo
    Chueca, Natalia
    Guerrero-Beltran, Carlos
    Rodriguez, Carmen
    Imaz, Arkaitz
    Espinosa, Nuria
    Garcia-Bujalance, Silvia
    Jesus Perez-Elias, Maria
    Garcia-Alvarez, Monica
    Antonio Iribarren, Jose
    Santos, Jesus
    Dalmau, David
    Aguilera, Antonio
    Vinuesa, David
    Gutierrez, Felix
    Pierola, Beatriz
    Miguel Molina, Jose
    Peraire, Joaquim
    Portilla, Irene
    Luis Gomez-Sirvent, Juan
    Olalla, Julian
    Galera, Carlos
    Ramon Blanco, Jose
    Riera, Melchor
    Garcia-Fraile, Lucio
    Navarro, Gemma
    Curran, Adrian
    Poveda, Eva
    Garcia, Federico
    Moreno, Santiago
    Jarrin, Inma
    Dalmau, David
    Navarro, Maria Luisa
    Gonzalez, Maria Isabel
    Blanco, Jose Luis
    Garcia, Federico
    Rubio, Rafael
    Iribarren, Jose Antonio
    Gutierrez, Felix
    Vidal, Francesc
    Berenguer, Juan
    Gonzalez, Juan
    Alejos, Belen
    Hernando, Victoria
    Moreno, Cristina
    Iniesta, Carlos
    Sousa, Luis Miguel Garcia
    Perez, Nieves Sanz
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1693 - 1700
  • [27] Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequences
    Grobler, Jay A.
    Hazuda, Dana J.
    CURRENT OPINION IN VIROLOGY, 2014, 8 : 98 - 103
  • [28] Resistance to HIV integrase strand transfer inhibitors in Argentina: first interim survey
    Cecchini, Diego M.
    Castillo, Sonia
    Copertari, Gaston
    Lacal, Veronica
    Rodriguez, Claudia G.
    Cassetti, Isabel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (03) : 263 - 267
  • [29] Subtype Diversity Associated with the Development of HIV-1 Resistance to Integrase Inhibitors
    Brenner, Bluma G.
    Lowe, Matthew
    Moisi, Daniela
    Hardy, Isabelle
    Gagnon, Simon
    Charest, Hugues
    Baril, Jean Guy
    Wainberg, Mark A.
    Roger, Michel
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (05) : 751 - 759
  • [30] Accumulation of mutations in vivo confer cross-resistance to new integrase inhibitors
    Zhang, W. W.
    Cheung, P. K.
    Oliveira, N. S.
    Robbins, M.
    Harrigan, P. R.
    Shahid, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 139 - 139
12345